Amanote Research
Register
Sign In
PW01-015 – Canakinumab in Adults With Colchicin Resistant FMF
Pediatric Rheumatology
- United Kingdom
doi 10.1186/1546-0096-11-s1-a68
Full Text
Open PDF
Abstract
Available in
full text
Categories
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Date
November 1, 2013
Authors
A Gül
H Özdoğan
Ö Kasapçopur
B Erer
S Uğurlu
N Davis
S Sevgi
Publisher
Springer Science and Business Media LLC
Related search
PW01-032 – FMF-like State: Genetic Factors Unrelated to MEFV
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Colchicine Plus Dapsone in Colchicine‐Resistant FMF Patients
Case Reports in Rheumatology
P01-027 – Normal HRV in Colchicine-Resistant FMF Patients
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
P01-031 – Anakinra for Colchicine Resistant FMF
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Assessment of Effectiveness of Anakinra and Canakinumab in Patients With Colchicine-Resistant/Unresponsive Familial Mediterranean Fever
Advances in Rheumatology
Rheumatology
Therapy With Canakinumab for Gout
Nauchno-Prakticheskaya Revmatologiya
Rheumatology
Allergy
Immunology
Update on the Management of Colchicine Resistant Familial Mediterranean Fever (FMF)
Orphanet Journal of Rare Diseases
Medicine
Genetics
Pharmacology
Canakinumab Therapy in Patients With Familial Mediterranean Fever
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Renal Amyloidosis in Deficiency of Adenosine Deaminase 2: Successful Experience With Canakinumab
Pediatrics
Child Health
Pediatrics
Perinatology